JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY) ›› 2017, Vol. 31 ›› Issue (1): 95-99.doi: 10.6040/j.issn.1673-3770.0.2016.203

Previous Articles     Next Articles

Efficacy of recombinant human epidermal growth factor in prevention of radioactive oral mucosa inflammation and acute radiation dermatitis for nasopharyngeal carcinoma.

  

  1. Department of Radiation Oncology, Liuzhou Peoples Hospital, Liuzhou 545006, Guangxi, China
  • Received:2016-05-09 Online:2017-02-16 Published:2017-02-16

Abstract: Objective To observe the efficacy of recombinant human epidermal growth factor(rhEGF)in prevention of radioactive oral mucosa inflammation and acute radiation dermatitis of nasopharyngeal carcinoma(NPC). Methods A total of 50 NPC patients(5 stage Ⅱ, 32 stageⅢ and 13 stage Ⅳa)in the department of radiation oncology of our hospital hospitalized from January 2014 to December 2015 were randomly divided into the experimental group(n=26)and the control group(n=24).The two groups were treated with intensity modulated radiation therapy on the whole course, 6 weeks a radiotherapy cycle. The control group was given cisplatin single agent chemotherapy, and every 7 days for a cycle, 5 to 6 cycles. On the basis of the treatment of the control group, the experimental group was treated with combination of rhEGF(oral spray and neck skin smear gel)in the same period of the treatment. Short-term efficacy of the two groups was evaluated with complete remission, partial remission, stable disease and progression disease. The toxicity and side-effects were evaluated by the National Cancer Institute Common Toxicity Criteria(NCI-CTC). Results The short-term efficacy of the two groups was basically equivalent(P>0.05). No patients died in the two groups due to the toxic side effects, and the main toxicities in the two groups were gastrointestinal toxicity, myelosuppression and abnormal liver function. All patients had happened radioactive oral mucosa inflammation and acute radiation dermatitis of the neck which level was over grade Ⅰ. The incidence of radioactive oral mucosa inflammation and acute radiation dermatitis of the neck over grade Ⅱ level in the experimental group(42.31% and 11.54%)were significantly lower than those of the control group(70.83% and 41.67%)(P=0.042, 0.035). Conclusion The method of combination radiotherapy and chemotherapy with rhEGF in the treatment of NPC can effectively reduce the incidence of 山东大学耳鼻喉眼学报31卷1期 -于斌,等.重组人表皮生长因子预防鼻咽癌放射性口腔黏膜炎和急性放射性皮炎的疗效观察 \=-toxicity and side-effects of radioactive oral mucosa inflammation and acute radiation dermatitis of neck which caused by radiotherapy and chemotherapy.

Key words: Recombinanthuman epidermal growth factor, Radioactive oral mucosa inflammation, Nasopharyngeal carcinoma, Acute radiation dermatitis of the neck

CLC Number: 

  • R739.63
[1] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016[J]. CA Cancer J Clin, 2016, 66(1):7-30.
[2] 司勇锋,陶仲强.鼻咽癌病因学和防治研究[J].中国耳鼻咽喉头颈外科,2010,17(3):163-165.
[3] Cao SM, Liu ZW, Jia WH, et al. Fluctuations of epstein-barr virus serological antibodies and risk for nasopharyngeal carcinoma: a prospective screening study with a 20-year follow-up[J]. PLoS One, 2011, 6(4):e19100.
[4] Cao SM, Simons MJ, Qian CN. The prevalence and prevention of nasopharyngeal carcinoma in China[J]. Chin J Cancer, 2011, 30(2):114-119.
[5] 黄启洪,李艳华.四会市1978-2007年鼻咽癌发病趋势分析[J].中国肿瘤,2011,20(8):571-572. HUANG Qihong, LI Yanhua. An Analysis of Trend for Nasopharyngeal Carcinoma Incidence from 1978 to 2007 in Sihui City, Guangdong Province[J]. Chin Cancer, 2011, 20(8):571-572.
[6] 黄祥,曲超,姜新,等.鼻咽癌的治疗进展[J].中国老年学杂志,2015,35(11):3159-3161.
[7] Guigay J. Advances in nasopharyngeal carcinoma[J]. Curr Opin Oncol, 2008, 20(3):264-269.
[8] 钟海林, 陈国谋, 林丹平,等.69例鼻咽癌常规放疗与调强放疗的不良反应比较[J].临床耳鼻咽喉头颈外科杂志,2013,27(9):462-464. ZHONG Hailin, CHEN Guomou, LIN Danping, et al. Comparison of side effects of intensity modulated radiotherapy and conventional radiotherapy in 69cases with nasopharyngeal carcinoma[J]. Clin Otolaryngol Head Neck Surgery, 2013, 27(9):462-464.
[9] 蒋靖, 夏立君.他克莫司软膏联合重组人表皮生长因子凝胶治疗面部激素依赖性皮炎39例[J].中国皮肤性病学杂志, 2012, 26(6):506-508. JIANG Jing, XIA Lijun. Thirty-nine cases of hormone-dependent facial dermatitis treated with tacrolimus ointment and recombinant human epidermal growth factor gel[J]. Chin J Dermatovenereol, 2012, 26(6):506-508.
[10] 中国鼻咽癌临床分期工作委员会.鼻咽癌'92分期修订工作报告[J].中华放射肿瘤学杂志,2009,18(1):2-5.
[11] Schwartz LH, Bogaerts J, Ford R, et al. Evaluation of lymph nodes with RECIST 1.1.[J]. Eur J Cancer, 2009, 45(2):261-267.
[12] 傅志超,程惠华,李东石,等.鼻咽癌强调放疗联合尼妥珠单抗加同期顺铂化疗的临床观察[J].中国肿瘤防治杂志, 2011,18(18):1475-1477.
[13] 张典刚, 黄莉, 耿晓涛, 等. 局部晚期鼻咽癌强调放疗远期疗效分析[J]. 新疆医科大学学报, 2015, 38(1):17-20, 25. ZHANG Diangang, HUANG Li, GENG Xiaotao, et al. Long-term results in locally advanced nasopharyngeal carcinoma treated by intensity-modulated radiotherapy[J]. J Xinjiang Med Univ, 2015, 38(1):17-20, 25.
[14] ICRU report 50: Prescribing, recording, and reporting photon beam therapy[S]. Bethesda, MD: International Commission on Radiation Units and Measurem ents, 1993.
[15] ICRU report 62: Prescribing, recording, and reporting photon beam therapy(supplement to ICRU Report 50)[S]. Bethesda, MD: International Commission on Radiation Units and Measurem ents, 1999.
[16] 王跃建,邓燕明,虞幼军,等.鼻咽癌诊断和治疗[M].北京:人民卫生出版社, 2013:440.
[17] Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group(RTOG)and the European Organization for Research and Treatment of Cancer(EORTC)[J]. Int J Radiat Oncol Biol Phys, 1995, 31(5):1341-1346.
[18] 杜立法,王俊杰.放疗杀伤肿瘤细胞机制的研究进展[J].癌症进展,2014,12(4):341-345.
[19] 戴如立,林广明,骆映峰,等.重组人表皮细胞生长因子治疗急性放射性皮肤溃疡的临床观察[J].中国现代药物应用,2010,4(16):59-60.
[20] 刘尚贤,张春. 重组人表皮细胞生长因子在鼻咽癌放疗中预防放射性口咽炎疗效观察[J].中国医药科学,2014,4(20):168-169,172.
[21] 龚倩,谌赟,符一岚,等. 重组人表皮细胞生长因子联合氨磷汀治疗鼻咽癌患者放射性口腔黏膜炎的临床观察[J].中国药房,2015,26(14):1971-1973.
[22] Miyazaki M, Mars WM, Runge D, et al. Phenobarbital suppresses growth and accelerates restoration of differentiation markers of primary culture rat hepatocytes in the chemically defined hepatocyte growth medium containing hepatocyte growth factor and epidermal growth factor[J]. Exp Cell Resh, 1998, 241(2):445-457.
[23] Hong JP, Lee SW, Song SY, et al. Recombinant human epidermal growth factor treatment of radiation-induced severe oral mucositis in patients with head and neck malignancies[J]. Eur J Cancer Care(Engl), 2009, 18(6):636-641.
[24] Hong JP, Jung HD, Kim YW. Recombinant human epidermal growth factor(EGF)to enhance healing for diabetic foot ulcers[J]. Ann Plast Surg, 2006, 56(4):394-398; discussion 399-400.
[25] 吴宏,李燕,陈洁.重组人表皮生长因子凝胶与硝酸银软膏联合治疗放射性皮肤损伤[J].现代中西医结合杂志,2011,21(15):1678-1679.
[26] 郭杏,谭美云,郭力,等.重组人表皮细胞生长因子对供皮区创面的修复[J].中国组织工程研究,2010,14(5):862-865.
[1] LIN Xiaoxue, LIN Baorui, LI Peishan, LU Biaoqing. Application of electronic nasopharyngoscopy combined with narrow band imaging in traditional Chinese medicine syndrome differentiation of nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(3): 40-46.
[2] WANG Sheng, LI Yindan, YANG Jinji. The role of microRNA in nasopharyngeal carcinoma and its research progress [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 125-131.
[3] QIU Qianhui, XIAO Xuping, YANG Qintai, YE Jing, DENG Zeyi, WANG Desheng, TAN Guolin, JIANG weihong,. Expert consensus on clinical management recommendations for carotid blowout syndrome secondary to NPC treatment [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 1-18.
[4] WANG Siquan, ZHU Hongshen, ZHANG Xiaobin, ZHAO Zhouyang, MA Yue, YANG Yimei, HUANG Lijin. Analysis of factors associated with stroke and cranial nerve palsy after unilateral internal carotid artery embolization in patients with nasopharyngeal carcinoma after radiotherapy [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 19-25.
[5] HUANG Qiao, REN Yi, HOU Tao, LIAO Xingwei, ZHU Zi’ang, ZHAN Xiaolin, LIU Ying, YIN Shihua. Expression of EphB2 in nasopharyngeal carcinoma tissues and its correlation with clinicopathological characteristics [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 26-30.
[6] SUN Chunxiao, WANG Wenqing, YUE Tian, LIU Jisheng. Efficacy analysis of concurrent chemoradiotherapy with high and low cumulative cisplatin doses in the treatment of nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 31-41.
[7] WANG Zaixing, TANG Zhiyuan, LI Dingbo, SHI Zhaohui, ZENG Xianhai, ZHANG Qiuhang. Treatment of internal carotid artery rupture caused by tumor recurrence and skull base osteonecrosis after radiotherapy for nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 49-58.
[8] SUN Fang, XIE Chubo, QIU Qianhui. Retrospective analysis of nutritional indexes and their impact on wound healing in patients with radiation-induced skull base osteoradionecrosis after treatment with nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 59-68.
[9] ZHU Ruikai, WU Jiarong, SUN Fang, XIE Chubo, QIU Qianhui. Computed tomography angiography-based assessment of internal carotid artery stenosis after radiotherapy for nasopharyngeal carcinoma and its associated factors [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 77-84.
[10] QIN Debo, XUE Jiancheng, YANG Wenyue, HU Bing, CHEN Tao, YU Yanping, MENG Qingguo, SUN Huanji, MIAO Beiping, LU Yongtian. Changing the diagnosis and treatment of nasopharyngeal cancer: biomarkers and nasal endoscopic surgery synergise to advance early treatment development [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 85-92.
[11] WU Jiarong, QIU Qianhui. The role and significance of the skull base fascial tissue barrier in endoscopic resection of locally early recurrent nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 108-113.
[12] YANG Ming, LIU Xuexia, ZHANG Hua. Progress of m6A recognition protein IGF2BPs in head and neck cancer [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(3): 153-161.
[13] WU Min, LI Zhengyang, MENG Jie, YE Huiping. Molecular mechanisms of programmed cell death and its role in nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(2): 152-157.
[14] ZHANG Maohua, WEI Rifu, ZHU Zhongshou, LIU Ping, GAO Shang, LI Huifeng. Effect of LncRNA PCAT-1 on the biological behaviour and chemosensitivity of nasopharyngeal carcinoma cells [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(1): 68-76.
[15] ZHANG Jingyi, DONG Xiangyi, MU Yakui, SONG Xicheng. Research progress on pyroptosis in otorhinolaryngology diseases [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(4): 140-148.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!